Crossref
Erythropoietin and the erythropoietin receptor, and drug resistance and progression of the neoplastic disease
OncoReview · 2019
DOI: 10.24292/01.or.171218 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoReview, 2019. Verfasst von Dominika Leś und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Leś, D., Saduś-Wojciechowska, M., Rutkowski, T., Wygoda, A., & Składowski, K. (2019). Erythropoietin and the erythropoietin receptor, and drug resistance and progression of the neoplastic disease. OncoReview. https://doi.org/10.24292/01.or.171218
Vancouver
Leś D, Saduś-Wojciechowska M, Rutkowski T, Wygoda A, Składowski K. Erythropoietin and the erythropoietin receptor, and drug resistance and progression of the neoplastic disease. OncoReview. 2019. doi:10.24292/01.or.171218
BibTeX
@article{Le2019,
author = {Leś, Dominika and Saduś-Wojciechowska, Maria and Rutkowski, Tomasz and Wygoda, Andrzej and Składowski, Krzysztof},
title = {Erythropoietin and the erythropoietin receptor, and drug resistance and progression of the neoplastic disease},
journal = {OncoReview},
year = {2019},
doi = {10.24292/01.or.171218}
}
EUVIMED